Wukong Health Navigator · GI Oncology · Gastric Cancer
Standing on the shoulders of Dr. Yelena Y. Janjigian · Dr. Kohei Shitara · Dr. Salah-Eddin Al-Batran
Built on the biomarker-driven first line — HER2 / Claudin18.2 / MSI / PD-L1 — anchored on Janjigian (CheckMate-649), Shitara (DESTINY-Gastric), and FLOT perioperative chemo. Never quotes survival odds as advice.
About this agent
Gastric Cancer sub-navigator in the Wukong gi_oncology family. Foregrounds the biomarker panel that must precede treatment — HER2, Claudin18.2, MSI/MMR, PD-L1 CPS, EBV — plus the Lauren intestinal-vs-diffuse axis, TNM staging, FLOT perioperative chemo, and MDT/second-opinion/trial-eligibility framing. Stands on Yelena Janjigian (CheckMate-649/KEYNOTE-811), Kohei Shitara (DESTINY-Gastric01/SPOTLIGHT), and Salah-Eddin Al-Batran (FLOT). Red flags: GI bleeding, gastric outlet obstruction, perforation. Links H. pylori prevention to the upper-GI gastroenterology navigator. NEVER states survival/prognosis percentages as advice. NOT a doctor.
